Infant formula should provide the appropriate nutrients and adequate energy to facilitate healthy infant growth and development. If conclusive data on quantitative nutrient requirements are not available, the composition of human milk (HM) can provide some initial guidance on the infant formula composition. This paper provides a narrative review of the current knowledge, unresolved questions, and future research needs in the area of HM fatty acid (FA) composition, with a particular focus on exploring appropriate intake levels of the essential FA linoleic acid (LA) in infant formula. The paper highlights a clear gap in clinical evidence as to the impact of LA levels in HM or formula on infant outcomes, such as growth, development, and long-term health. The available preclinical information suggests potential disadvantages of high LA intake in the early postnatal period. We recommend performing well-designed clinical intervention trials to create clarity on optimal levels of LA to achieve positive impacts on both short-term growth and development and long-term functional health outcomes.

Perspective: moving toward desirable linoleic acid content in infant formula / S.E. Carlson, L. Schipper, J.T. Brenna, C. Agostoni, P.C. Calder, S. Forsyth, P. Legrand, M. Abrahamse-Berkeveld, B.J.M. van de Heijning, E.M. van der Beek, B.V. Koletzko, B. Muhlhausler. - In: ADVANCES IN NUTRITION. - ISSN 2161-8313. - 12:6(2021 Dec 01), pp. 2085-2098. [10.1093/advances/nmab076]

Perspective: moving toward desirable linoleic acid content in infant formula

C. Agostoni;
2021

Abstract

Infant formula should provide the appropriate nutrients and adequate energy to facilitate healthy infant growth and development. If conclusive data on quantitative nutrient requirements are not available, the composition of human milk (HM) can provide some initial guidance on the infant formula composition. This paper provides a narrative review of the current knowledge, unresolved questions, and future research needs in the area of HM fatty acid (FA) composition, with a particular focus on exploring appropriate intake levels of the essential FA linoleic acid (LA) in infant formula. The paper highlights a clear gap in clinical evidence as to the impact of LA levels in HM or formula on infant outcomes, such as growth, development, and long-term health. The available preclinical information suggests potential disadvantages of high LA intake in the early postnatal period. We recommend performing well-designed clinical intervention trials to create clarity on optimal levels of LA to achieve positive impacts on both short-term growth and development and long-term functional health outcomes.
linoleic acid; LCPUFAs; human milk composition; infant development; infant formula; nutritional programming
Settore MED/38 - Pediatria Generale e Specialistica
Settore MEDS-20/A - Pediatria generale e specialistica
1-dic-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
nmab076.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.31 MB
Formato Adobe PDF
1.31 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1059760
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 18
  • OpenAlex ND
social impact